Another higher offer is expected from UTHR United Therapeutics prior to the 4/27 pdufa for Treyvant. Corv was wise to "accept the arrangement" so they could publish the potential buyout to force UTHR to the table. do your DD...Corv is not selling their entire company for $76M when UTHR paid over $200M for steadymed last year just for US rights to Treyvant..know what you own!